Found 7 resultsAuthor Title Type [ Year]
Filters: First Letter Of Title is S and Author is Fast, P [Clear All Filters]
Safety, Adherence and Acceptability of Intermittent Tenofovir/Emtricitabine as HIV Pre-exposure Prophylaxis (PrEP) among HIV-Uninfected Ugandan Volunteers Living in HIV-Serodiscordant Relationships: A Randomized, Clinical Trial. PLoS One, 8, e74314. presented at the 09/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24086333. (2013).
Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers. PLoS One, 7, e33103. presented at the 04/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22511916. (2012).
Safety and Immunogenicity of VRC Multiclade HIV-1 Adenoviral Vector Vaccine Alone or with VRC Multiclade HIV-1 DNA Plasmid Vaccine in the African Adults. In AIDS Vaccine 2007 Conference. presented at the 20/08/2007, Seattle, WA. Retrieved from http://www.vaccineenterprise.org/conference_archive/2007/index.html. (2007).
Studies of a Prophylactic HIV-1 Vaccine Candidate Based on Modified Vaccinia Virus Ankara (MVA) with and without DNA Priming: Effects of Dosage and Route on Safety and Immunogenicity. Vaccine, 25, 2120-2127. presented at the 03/2007. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17250931. (2007).
Safety and Immunogenicity of MVA.HIVA by 3 Different Routes. In AIDS Vaccine 2005 International Conference. presented at the 06/09/2005, Montreal, Quebec, Canada.. (2005).
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group. AIDS Res Hum Retroviruses, 13(14), 1163-77. presented at the 1997 Sep 20. doi:10.1089/aid.1997.13.1163. (1997).